Appendicitis among liver transplant recipients has not been described in the current literature. We report 8 recipients who experienced appendicitis three weeks to 181 months after liver transplantation (LT). Initial presenting findings differed from the nonimmunosuppressed population in that a majo
Probabilities of relapse and abstinence among liver transplant recipients
β Scribed by Thomas P. Beresford
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 54 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20752
No coin nor oath required. For personal study only.
β¦ Synopsis
Andrea DiMartini and her colleagues have provided prospectively gathered data on the course of alcohol use among liver transplant recipients during the first 5 years of postgraft living. Having worked with the difficult issue of alcohol use disorders and liver transplantation for a number of years now, I know the results of her study will be viewed in many ways.
One frame of reference-that of the most exacting utilitarianism untroubled by the vicissitudes of human experience-might conclude, "There is nothing here that I can use. Alcohol-dependent people are likely to drink heavily: no surprise there. The investigators found no empirical cut point for pretransplant abstinence that we can use in selection: again, no help. And 1 in 4 alcoholic graft recipients were back drinking heavily within 5 years. How can I explain that when I'm talking with a donor parent of a child killed by a drunk driver?" This stance pays no attention to Sir William Osler's conclusion that "Medicine is a science of uncertainty and an art of probability." 1 An opposite theoretical stance-one holding that technical idealism will save us all-might view Dr. DiMartini's results and say, "Wow! Three out of 5 alcoholics didn't drink any alcohol in 5 years, and 3 out of 4 never returned to pathological drinking in that time!
π SIMILAR VOLUMES
Eighty-four patients with the diagnosis of end-stage alcoholic liver arate analysis of high-risk patients with poly-drug use disease underwent liver transplantation from April, 1986 to July, (n Γ 15, alcohol recidivism 8/15, 53%) and the remaining 1994. A diagnosis of alcohol dependence was establis
There has been an increase in the incidence of visceral leishmaniasis (VL), especially among hemopoietic and renal transplant recipients. [1][2][3] Remarkably, very few cases have been described among liver transplant recipients. We report a case of VL in a liver transplant recipient and analyze the
Segmental liver transplantation with living donor (LD), reduced cadaveric (Reduced), and split cadaveric (Split) allografts has expanded the availability of size-appropriate organs for pediatric recipients. The relevance of recipient age to the selection of graft type has not been fully explored, bu
Liver allografts exhibit intrinsic tolerogenic properties that result in their spontaneous acceptance in many experimental animal models. (2) In clinical transplantation, liver allografts require milder immunosuppression (IS) regimens than other organs, are remarkably resistant to antibody-mediated
Toxoplasmosis is a serious and potentially life-threatening disease in liver transplant recipients while they are immunosuppressed. We report the clinical and laboratory findings related to active toxoplasma infection associated with 40 immunosuppressed liver transplant procedures that took place ov